| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -75 @ USD 143.6 | USD -10,770 | The ETF sold 75 shares of DVA on 2025-05-15. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 806 The average price that the ETF previously sold DVA share for is USD 153.585 which is higher than the selling price of USD 143.6 on 2025-05-15. |
| CRL - Creightons Plc | SELL | -84 @ USD 138.89 | USD -11,667 | The ETF sold 84 shares of CRL on 2025-05-15. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -17.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,465 The average price that the ETF previously sold CRL share for is USD 189.393 which is higher than the selling price of USD 138.89 on 2025-05-15. |
| TECH - Bio-Techne Corp | SELL | -261 @ USD 48.24 | USD -12,591 | The ETF sold 261 shares of TECH on 2025-05-15. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -25.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,376 The average price that the ETF previously sold TECH share for is USD 70.8687 which is higher than the selling price of USD 48.24 on 2025-05-15. |
| MRNA - Moderna Inc | SELL | -552 @ USD 23.65 | USD -13,055 | The ETF sold 552 shares of MRNA on 2025-05-15. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -33.2% lower than average price of previous purchases. This resulted in an overall loss of USD 6,481 The average price that the ETF previously sold MRNA share for is USD 41.8156 which is higher than the selling price of USD 23.65 on 2025-05-15. |
| HSIC - Henry Schein Inc | SELL | -207 @ USD 71.54 | USD -14,809 | The ETF sold 207 shares of HSIC on 2025-05-15. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 267 The average price that the ETF previously sold HSIC share for is USD 71.0893 so the ETF has sold 207 shares on 2025-05-15 at a higher price than the previous selling average. |
| SOLV - Solventum Corp. | SELL | -222 @ USD 72.94 | USD -16,193 | The ETF sold 222 shares of SOLV on 2025-05-15. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 268 The average price that the ETF previously sold SOLV share for is USD 70.2071 so the ETF has sold 222 shares on 2025-05-15 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -267 @ USD 62.76 | USD -16,757 | The ETF sold 267 shares of INCY on 2025-05-15. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,668 The average price that the ETF previously sold INCY share for is USD 72.6273 which is higher than the selling price of USD 62.76 on 2025-05-15. |
| VTRS - Viatris Inc | SELL | -2,004 @ USD 8.79 | USD -17,615 | The ETF sold 2004 shares of VTRS on 2025-05-15. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -15.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,223 The average price that the ETF previously sold VTRS share for is USD 12.1845 which is higher than the selling price of USD 8.79 on 2025-05-15. |
| UHS - Universal Health Services Inc | SELL | -93 @ USD 195.88 | USD -18,217 | The ETF sold 93 shares of UHS on 2025-05-15. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 633 The average price that the ETF previously sold UHS share for is USD 192.624 so the ETF has sold 93 shares on 2025-05-15 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -204 @ USD 90.4 | USD -18,442 | The ETF sold 204 shares of RVTY on 2025-05-15. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -19.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,402 The average price that the ETF previously sold RVTY share for is USD 114.04 which is higher than the selling price of USD 90.4 on 2025-05-15. |
| HOLX - Hologic Inc | SELL | -372 @ USD 55.74 | USD -20,735 | The ETF sold 372 shares of HOLX on 2025-05-15. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -16.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,152 The average price that the ETF previously sold HOLX share for is USD 72.343 which is higher than the selling price of USD 55.74 on 2025-05-15. |
| ALGN - Align Technology Inc | SELL | -117 @ USD 186.72 | USD -21,846 | The ETF sold 117 shares of ALGN on 2025-05-15. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 181 The average price that the ETF previously sold ALGN share for is USD 215.572 which is higher than the selling price of USD 186.72 on 2025-05-15. |
| WST - West Pharmaceutical Services Inc | SELL | -117 @ USD 210.68 | USD -24,650 | The ETF sold 117 shares of WST on 2025-05-15. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,338 The average price that the ETF previously sold WST share for is USD 305.242 which is higher than the selling price of USD 210.68 on 2025-05-15. |
| BAX - Baxter International Inc | SELL | -840 @ USD 31.04 | USD -26,074 | The ETF sold 840 shares of BAX on 2025-05-15. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,916 The average price that the ETF previously sold BAX share for is USD 32.4405 which is higher than the selling price of USD 31.04 on 2025-05-15. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -336 @ USD 81.45 | USD -27,367 | The ETF sold 336 shares of COO on 2025-05-15. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -8.6% lower than average price of previous purchases. This resulted in an overall loss of USD 2,567 The average price that the ETF previously sold COO share for is USD 96.1978 which is higher than the selling price of USD 81.45 on 2025-05-15. |
| MOH - MOH | SELL | -90 @ USD 313.97 | USD -28,257 | The ETF sold 90 shares of MOH on 2025-05-15. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 404 The average price that the ETF previously sold MOH share for is USD 306.438 so the ETF has sold 90 shares on 2025-05-15 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -90 @ USD 313.97 | USD -28,257 | The ETF sold 90 shares of MOH on 2025-05-15. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 404 The average price that the ETF previously sold MOH share for is USD 306.438 so the ETF has sold 90 shares on 2025-05-15 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -240 @ USD 123.7 | USD -29,688 | The ETF sold 240 shares of BIIB on 2025-05-15. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -15.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,266 The average price that the ETF previously sold BIIB share for is USD 158.016 which is higher than the selling price of USD 123.7 on 2025-05-15. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -327 @ USD 96.73 | USD -31,631 | The ETF sold 327 shares of ZBH on 2025-05-15. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,391 The average price that the ETF previously sold ZBH share for is USD 107.408 which is higher than the selling price of USD 96.73 on 2025-05-15. |
| DGX - Quest Diagnostics Incorporated | SELL | -186 @ USD 176.41 | USD -32,812 | The ETF sold 186 shares of DGX on 2025-05-15. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 1,747 The average price that the ETF previously sold DGX share for is USD 159.331 so the ETF has sold 186 shares on 2025-05-15 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -135 @ USD 246.27 | USD -33,246 | The ETF sold 135 shares of LH on 2025-05-15. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of USD 673 The average price that the ETF previously sold LH share for is USD 235.904 so the ETF has sold 135 shares on 2025-05-15 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -96 @ USD 351.6 | USD -33,754 | The ETF sold 96 shares of WAT on 2025-05-15. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,695 The average price that the ETF previously sold WAT share for is USD 372.525 which is higher than the selling price of USD 351.6 on 2025-05-15. |
| WAT - MULETFWATIMETFP | SELL | -96 @ USD 351.6 | USD -33,754 | The ETF sold 96 shares of WAT on 2025-05-15. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,695 The average price that the ETF previously sold WAT share for is USD 372.525 which is higher than the selling price of USD 351.6 on 2025-05-15. |
| PODD - Insulet Corporation | SELL | -114 @ USD 322.02 | USD -36,710 | The ETF sold 114 shares of PODD on 2025-05-15. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 20.1% higher than average price of previous purchases. This sale made a profit of USD 6,137 The average price that the ETF previously sold PODD share for is USD 262.143 so the ETF has sold 114 shares on 2025-05-15 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -33 @ USD 1143.36 | USD -37,731 | The ETF sold 33 shares of MTD on 2025-05-15. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,169 The average price that the ETF previously sold MTD share for is USD 1239.75 which is higher than the selling price of USD 1143.36 on 2025-05-15. |
| MTD - AMUNDI EUR GOV 710 | SELL | -33 @ USD 1143.36 | USD -37,731 | The ETF sold 33 shares of MTD on 2025-05-15. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,169 The average price that the ETF previously sold MTD share for is USD 1239.75 which is higher than the selling price of USD 1143.36 on 2025-05-15. |
| IQV - IQVIA Holdings Inc | SELL | -276 @ USD 140.43 | USD -38,759 | The ETF sold 276 shares of IQV on 2025-05-15. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -26.7% lower than average price of previous purchases. This resulted in an overall loss of USD 14,127 The average price that the ETF previously sold IQV share for is USD 197.773 which is higher than the selling price of USD 140.43 on 2025-05-15. |
| STE - STERIS plc | SELL | -162 @ USD 246.88 | USD -39,995 | The ETF sold 162 shares of STE on 2025-05-15. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 11.2% higher than average price of previous purchases. This sale made a profit of USD 4,016 The average price that the ETF previously sold STE share for is USD 214.969 so the ETF has sold 162 shares on 2025-05-15 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -198 @ USD 227.47 | USD -45,039 | The ETF sold 198 shares of HUM on 2025-05-15. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,428 The average price that the ETF previously sold HUM share for is USD 277.618 which is higher than the selling price of USD 227.47 on 2025-05-15. |
| HUM - Humana Inc | SELL | -198 @ USD 227.47 | USD -45,039 | The ETF sold 198 shares of HUM on 2025-05-15. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,428 The average price that the ETF previously sold HUM share for is USD 277.618 which is higher than the selling price of USD 227.47 on 2025-05-15. |
| CNC - Concurrent Technologies Plc | SELL | -828 @ USD 60.06 | USD -49,730 | The ETF sold 828 shares of CNC on 2025-05-15. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of USD 48 The average price that the ETF previously sold CNC share for is USD 60.0635 which is higher than the selling price of USD 60.06 on 2025-05-15. |
| A - Agilent Technologies Inc | SELL | -471 @ USD 112.4 | USD -52,940 | The ETF sold 471 shares of A on 2025-05-15. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 7,777 The average price that the ETF previously sold A share for is USD 132.703 which is higher than the selling price of USD 112.4 on 2025-05-15. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -750 @ USD 72.91 | USD -54,683 | The ETF sold 750 shares of GEHC on 2025-05-15. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,943 The average price that the ETF previously sold GEHC share for is USD 81.3061 which is higher than the selling price of USD 72.91 on 2025-05-15. |
| DXCM - DexCom Inc | SELL | -648 @ USD 85.67 | USD -55,514 | The ETF sold 648 shares of DXCM on 2025-05-15. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 5,045 The average price that the ETF previously sold DXCM share for is USD 75.5082 so the ETF has sold 648 shares on 2025-05-15 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -240 @ USD 248.58 | USD -59,659 | The ETF sold 240 shares of RMD on 2025-05-15. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 3,446 The average price that the ETF previously sold RMD share for is USD 239.921 so the ETF has sold 240 shares on 2025-05-15 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -399 @ USD 151.95 | USD -60,628 | The ETF sold 399 shares of CAH on 2025-05-15. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 18.4% higher than average price of previous purchases. This sale made a profit of USD 9,424 The average price that the ETF previously sold CAH share for is USD 122.125 so the ETF has sold 399 shares on 2025-05-15 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -132 @ USD 511.99 | USD -67,583 | The ETF sold 132 shares of IDXX on 2025-05-15. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 16.1% higher than average price of previous purchases. This sale made a profit of USD 9,397 The average price that the ETF previously sold IDXX share for is USD 426.639 so the ETF has sold 132 shares on 2025-05-15 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -972 @ USD 76.88 | USD -74,727 | The ETF sold 972 shares of EW on 2025-05-15. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 5,444 The average price that the ETF previously sold EW share for is USD 70.2821 so the ETF has sold 972 shares on 2025-05-15 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -282 @ USD 285.97 | USD -80,644 | The ETF sold 282 shares of COR on 2025-05-15. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of USD 8,833 The average price that the ETF previously sold COR share for is USD 245.7 so the ETF has sold 282 shares on 2025-05-15 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -471 @ USD 172.27 | USD -81,139 | The ETF sold 471 shares of BDX on 2025-05-15. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -24.0% lower than average price of previous purchases. This resulted in an overall loss of USD 25,584 The average price that the ETF previously sold BDX share for is USD 224.234 which is higher than the selling price of USD 172.27 on 2025-05-15. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -171 @ USD 584.99 | USD -100,033 | The ETF sold 171 shares of REGN on 2025-05-15. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -17.0% lower than average price of previous purchases. This resulted in an overall loss of USD 20,437 The average price that the ETF previously sold REGN share for is USD 750.671 which is higher than the selling price of USD 584.99 on 2025-05-15. |
| HCA - HCA Holdings Inc | SELL | -291 @ USD 385.5 | USD -112,181 | The ETF sold 291 shares of HCA on 2025-05-15. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 14.1% higher than average price of previous purchases. This sale made a profit of USD 13,826 The average price that the ETF previously sold HCA share for is USD 326.55 so the ETF has sold 291 shares on 2025-05-15 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -732 @ USD 160.35 | USD -117,376 | The ETF sold 732 shares of ZTS on 2025-05-15. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,028 The average price that the ETF previously sold ZTS share for is USD 171.706 which is higher than the selling price of USD 160.35 on 2025-05-15. |
| CVS - CVS Health Corp | SELL | -2,064 @ USD 60.47 | USD -124,810 | The ETF sold 2064 shares of CVS on 2025-05-15. The shares were previously bought for an average price of USD 62.9223. The CVS Health Corp shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 5,062 The average price that the ETF previously sold CVS share for is USD 55.2956 so the ETF has sold 2064 shares on 2025-05-15 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -447 @ USD 308.86 | USD -138,060 | The ETF sold 447 shares of CI on 2025-05-15. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,534 The average price that the ETF previously sold CI share for is USD 312.794 which is higher than the selling price of USD 308.86 on 2025-05-15. |
| MCK - McKesson Corporation | SELL | -204 @ USD 706.76 | USD -144,179 | The ETF sold 204 shares of MCK on 2025-05-15. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of USD 17,377 The average price that the ETF previously sold MCK share for is USD 601.14 so the ETF has sold 204 shares on 2025-05-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -378 @ USD 390 | USD -147,420 | The ETF sold 378 shares of ELV on 2025-05-15. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 7,844 The average price that the ETF previously sold ELV share for is USD 401.985 which is higher than the selling price of USD 390 on 2025-05-15. |
| ELV - Elevance Health Inc | SELL | -378 @ USD 390 | USD -147,420 | The ETF sold 378 shares of ELV on 2025-05-15. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 7,844 The average price that the ETF previously sold ELV share for is USD 401.985 which is higher than the selling price of USD 390 on 2025-05-15. |
| BMY - Bloomsbury Publishing Plc | SELL | -3,321 @ USD 45.81 | USD -152,135 | The ETF sold 3321 shares of BMY on 2025-05-15. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -20.1% lower than average price of previous purchases. This resulted in an overall loss of USD 38,207 The average price that the ETF previously sold BMY share for is USD 56.6013 which is higher than the selling price of USD 45.81 on 2025-05-15. |
| MDT - Medtronic PLC | SELL | -2,094 @ USD 86.11 | USD -180,314 | The ETF sold 2094 shares of MDT on 2025-05-15. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,521 The average price that the ETF previously sold MDT share for is USD 85.3696 so the ETF has sold 2094 shares on 2025-05-15 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -417 @ USD 434.38 | USD -181,136 | The ETF sold 417 shares of VRTX on 2025-05-15. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 18,461 The average price that the ETF previously sold VRTX share for is USD 464.026 which is higher than the selling price of USD 434.38 on 2025-05-15. |
| DHR - Danaher Corporation | SELL | -1,044 @ USD 190.95 | USD -199,352 | The ETF sold 1044 shares of DHR on 2025-05-15. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 26,864 The average price that the ETF previously sold DHR share for is USD 231.79 which is higher than the selling price of USD 190.95 on 2025-05-15. |
| DHR - Danaher Corporation | SELL | -1,044 @ USD 190.95 | USD -199,352 | The ETF sold 1044 shares of DHR on 2025-05-15. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -11.9% lower than average price of previous purchases. This resulted in an overall loss of USD 26,864 The average price that the ETF previously sold DHR share for is USD 231.79 which is higher than the selling price of USD 190.95 on 2025-05-15. |
| GILD - Guild Esports Plc | SELL | -2,034 @ USD 100.34 | USD -204,092 | The ETF sold 2034 shares of GILD on 2025-05-15. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,392 The average price that the ETF previously sold GILD share for is USD 94.3301 so the ETF has sold 2034 shares on 2025-05-15 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -9,255 @ USD 22.6 | USD -209,163 | The ETF sold 9255 shares of PFE on 2025-05-15. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 29,677 The average price that the ETF previously sold PFE share for is USD 25.9671 which is higher than the selling price of USD 22.6 on 2025-05-15. |
| SYK - Stryker Corporation | SELL | -558 @ USD 392.2 | USD -218,848 | The ETF sold 558 shares of SYK on 2025-05-15. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 6,959 The average price that the ETF previously sold SYK share for is USD 374.668 so the ETF has sold 558 shares on 2025-05-15 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -876 @ USD 271.69 | USD -238,000 | The ETF sold 876 shares of AMGN on 2025-05-15. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 27,620 The average price that the ETF previously sold AMGN share for is USD 289.364 which is higher than the selling price of USD 271.69 on 2025-05-15. |
| BSX - Boston Scientific Corporation | SELL | -2,406 @ USD 104.86 | USD -252,293 | The ETF sold 2406 shares of BSX on 2025-05-15. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 14,857 The average price that the ETF previously sold BSX share for is USD 90.333 so the ETF has sold 2406 shares on 2025-05-15 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -2,406 @ USD 104.86 | USD -252,293 | The ETF sold 2406 shares of BSX on 2025-05-15. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 14,857 The average price that the ETF previously sold BSX share for is USD 90.333 so the ETF has sold 2406 shares on 2025-05-15 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -624 @ USD 404.93 | USD -252,676 | The ETF sold 624 shares of TMO on 2025-05-15. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -22.4% lower than average price of previous purchases. This resulted in an overall loss of USD 72,896 The average price that the ETF previously sold TMO share for is USD 523.212 which is higher than the selling price of USD 404.93 on 2025-05-15. |
| MRK - Marks Electrical Group PLC | SELL | -4,125 @ USD 74.8 | USD -308,550 | The ETF sold 4125 shares of MRK on 2025-05-15. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -18.6% lower than average price of previous purchases. This resulted in an overall loss of USD 70,419 The average price that the ETF previously sold MRK share for is USD 98.8431 which is higher than the selling price of USD 74.8 on 2025-05-15. |
| MRK - Merck & Company Inc | SELL | -4,125 @ USD 74.8 | USD -308,550 | The ETF sold 4125 shares of MRK on 2025-05-15. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -18.6% lower than average price of previous purchases. This resulted in an overall loss of USD 70,419 The average price that the ETF previously sold MRK share for is USD 98.8431 which is higher than the selling price of USD 74.8 on 2025-05-15. |
| ISRG - Intuitive Surgical Inc | SELL | -579 @ USD 560.28 | USD -324,402 | The ETF sold 579 shares of ISRG on 2025-05-15. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 11,105 The average price that the ETF previously sold ISRG share for is USD 530.405 so the ETF has sold 579 shares on 2025-05-15 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -2,826 @ USD 133.35 | USD -376,847 | The ETF sold 2826 shares of ABT on 2025-05-15. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 17,849 The average price that the ETF previously sold ABT share for is USD 117.596 so the ETF has sold 2826 shares on 2025-05-15 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,497 @ USD 274.35 | USD -410,702 | The ETF sold 1497 shares of UNH on 2025-05-15. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -47.7% lower than average price of previous purchases. This resulted in an overall loss of USD 373,930 The average price that the ETF previously sold UNH share for is USD 559.492 which is higher than the selling price of USD 274.35 on 2025-05-15. |
| ABBV - AbbVie Inc | SELL | -2,874 @ USD 181.68 | USD -522,148 | The ETF sold 2874 shares of ABBV on 2025-05-15. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -6.1% lower than average price of previous purchases. This resulted in an overall loss of USD 34,132 The average price that the ETF previously sold ABBV share for is USD 185.114 which is higher than the selling price of USD 181.68 on 2025-05-15. |
| JNJ - Johnson & Johnson | SELL | -3,921 @ USD 149.61 | USD -586,621 | The ETF sold 3921 shares of JNJ on 2025-05-15. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 32,815 The average price that the ETF previously sold JNJ share for is USD 152.614 which is higher than the selling price of USD 149.61 on 2025-05-15. |
| LLY - Eli Lilly and Company | SELL | -1,281 @ USD 733.29 | USD -939,344 | The ETF sold 1281 shares of LLY on 2025-05-15. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 133,680 The average price that the ETF previously sold LLY share for is USD 795.148 which is higher than the selling price of USD 733.29 on 2025-05-15. |